세계의 심부정맥질환 치료기기 시장 : 유형별, 최종사용자별 예측(2025-2030년)

The Deep Venous Disease Treatment Devices Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 1.83 billion by 2030.

Deep Venous Disease (DVD) Treatment Devices encompass a range of medical devices and technologies aimed at diagnosing and treating conditions affecting the deep venous system, including deep vein thrombosis (DVT) and chronic venous insufficiency (CVI). The necessity for these devices is driven by the increasing prevalence of sedentary lifestyles, aging populations, and rising incidences of cardiovascular diseases, which heighten the risk for venous disorders. Applications extend to hospitals, specialty clinics, and home healthcare settings, emphasizing the importance of tailored treatment approaches. End-users include healthcare providers, medical professionals, and patients seeking minimally invasive therapeutic solutions. Significant growth factors influencing the market are advancements in device technology, growing awareness on early diagnosis, and the demand for non-invasive treatment options. The emergence of novel therapies and favorable regulatory landscapes present potential opportunities for innovation and growth. Market participants can explore strategic collaborations and invest in R&D to develop next-generation venous devices that enhance efficacy and patient outcomes. However, challenges such as high treatment costs, stringent regulatory requirements, and the dearth of skilled professionals may pose hurdles to market expansion. Economic constraints in developing regions further impede growth potential. To mitigate these challenges, companies could focus on cost-effective product development and educational programs to bolster professional training. Areas ripe for innovation include wearable monitoring devices, artificial intelligence-assisted diagnostics, and biologically integrated treatment solutions that promote faster and more holistic healing processes. Key research efforts can pivot towards understanding the molecular mechanisms of DVD and enhancing current device biocompatibility and function. The market landscape is competitive and dynamic, characterized by rapid technological advancements and evolving healthcare demands, mandating market players to stay agile and forward-thinking to maintain a competitive edge while tapping into emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Venous Disease Treatment Devices Market

The Deep Venous Disease Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of deep vein diseases across the world
  • Rising awareness about preventative devices
• Market Restraints
  • Availability of alternative treatment options
• Market Opportunities
  • Ongoing research and development activities for deep vein disease devices
  • Development of personalized vascular tents and intermittent pneumatic compression devices
• Market Challenges
  • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Deep Venous Disease Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Venous Disease Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Venous Disease Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Venous Disease Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Venous Disease Treatment Devices Market

A detailed market share analysis in the Deep Venous Disease Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Venous Disease Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Venous Disease Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Venous Disease Treatment Devices Market

A strategic analysis of the Deep Venous Disease Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Venous Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Alma Lasers GMBH, Andratec GmbH, AngioDynamics, Inc., Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Cardinal Health, Imperative Care, Innova Vascular, Inc., Johnson & Johnson Medical NV, Kavya Pharma, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra Inc., Stryker Corporation, Surmodics, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Deep Venous Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Compression Device, Peripheral Vascular Stent, and Thrombectomy & Thrombolysis Device.
• Based on End User, market is studied across Ambulatory Surgical Centres and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of deep vein diseases across the world
    • 5.1.1.2. Rising awareness about preventative devices
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative treatment options
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for deep vein disease devices
    • 5.1.3.2. Development of personalized vascular tents and intermittent pneumatic compression devices
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Deep Venous Disease Treatment Devices Market, by Type

• 6.1. Introduction
• 6.2. Compression Device
• 6.3. Peripheral Vascular Stent
• 6.4. Thrombectomy & Thrombolysis Device

7. Deep Venous Disease Treatment Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centres
• 7.3. Hospitals & Clinics

8. Americas Deep Venous Disease Treatment Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Venous Disease Treatment Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Venous Disease Treatment Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Alma Lasers GMBH
• 4. Andratec GmbH
• 5. AngioDynamics, Inc.
• 6. Becton, Dickinson, and Company
• 7. Biolitec AG
• 8. Boston Scientific Corporation
• 9. Cardinal Health
• 10. Imperative Care
• 11. Innova Vascular, Inc.
• 12. Johnson & Johnson Medical NV
• 13. Kavya Pharma
• 14. Koninklijke Philips N.V.
• 15. Medtronic PLC
• 16. Merit Medical Systems, Inc.
• 17. Nipro Corporation
• 18. Penumbra Inc.
• 19. Stryker Corporation
• 20. Surmodics, Inc.
• 21. Teleflex Incorporated
• 22. Terumo Corporation